Assessment and clinical implications of absorption of sunscreens across skin

American Journal of Clinical Dermatology

Volumn 1, Issue 4, 2000, Pages 217-224

  Benson, Heather A E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ABSORPTION; HUMAN; METABOLISM; REVIEW; SKIN;

ABSORPTION; HUMANS; SKIN; SUNSCREENING AGENTS;

EID: 0034232584     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200001040-00003     Document Type: Article

References (47)

1. Society AC. URL http: //www.cancer.org/statistics/index.html. 2000
2. Federal Register. Sunscreen drug products for over-the-counter human use; Tentative final monograph; Proposed rule. Federal Register 1993 May 12: 28194-302
3. Federal Register. Sunscreen drug products for over-the-counter human use; Amendment to the tentative final monograph. Federal Register 1996; 61 Sep 16: 48645
4. Hayden CG, Roberts MS, Benson HA. Sunscreens: are Australians getting the good oil? Aust N Z J Med 1998; 28 (5): 639-46
5. Sayre RM, Kollias N, Roberts RL, et al. Physical sunscreens. J Soc Cosmetic Chemists 1990; 41: 103-9
6. Shaath NA. On the theory of ultraviolet absorption by sunscreen chemicals. J Soc Cosmetic Chemists 1987; 82: 193-207
7. Hayden CGJ, Benson HAE, Roberts MS. Sunscreens: Toxicological aspects. In: Roberts MS, Walters KA, editors. Dermal absorption and toxicity assessment. New York: Marcel Dekker, 1998: 537-99
8. Watkinson AC, Brain KR, Walters KA, et al. Prediction of the percutaneous penetration of ultra-violet filters used in sunscreen formulations. Int J Cosmet Sci 1992; 14 (265): 265-75
9. Agrapidis PL, Nash RA, Shaath NA. Effect of solvents on the ultraviolet absorbance of sunscreens. J Soc Cosmet Chem 1987; 38 (209): 209-21
10. Hayden CG, Roberts MS, Benson HA. Systemic absorption of sunscreen after topical application. Lancet 1997; 350 (9081): 863-4
11. Hany J, Nagel R. Detection of sunscreen agents in human breast milk. Deutsche Lebensmittel-Rundschau 1995; 91: 341-5
12. Feldman R, Maibach HI. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54: 399-404
13. Arancibia A, Borie G, Cornwell E, et al. Pharmacokinetic study on the percutaneous absorption of p-aminobenzoic acid from 3 sunscreen preparations. Farmaco Ed Prat 1981; 36 (357): 357-65
14. Dupuis D, Rougier A, Roguet R, et al. In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol 1984; 82 (4): 353-6
15. Dupuis D, Rougier A, Roguet R, et al. The measurement of the stratum corneum reservoir: a simple method to predict the influence of vehicles on in vivo percutaneous absorption. Br J Dermatol 1986; 115 (2): 233-8
16. Dupuis D, Rougier A, Lotte C, et al. An original predictive method for in vivo percutaneous absorption studies. Acta Derm Venereol Suppl. 1987; 134: 9-21
17. Treffel P, Gabard B. Skin penetration and sun protection factor of ultra-violet filters from two vehicles. Pharm Res 1996; 13 (5): 770-4
18. Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982; 62 (3): 481-8
19. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies III: hydrophobic compounds. J Pharm Sci 1984; 73 (9): 1255-8
20. Dal Pozza A, Liggeri E, Delucca C, et al. Prediction of skin permeation of highly lipophilic compounds; in vitro model with a modified receptor phase. Int J Pharmaceutics 1991; 70: 219-23
21. Jiang R, Roberts MS, Collins DM, et al. Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. Br J Clin Pharmacol 1999; 48 (4): 635-7
22. Hagedorn-Leweke U, Lippold BC. Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes. Pharm Res 1995; 12 (9): 1354-60
23. Benech F, Berthelot B, Wegrich P, et al. A comparative study of in vitro skin models: percutaneous absorption of sunscreens on pig and human skin. In: Brain KR, James VJ, Walters KA, editors. Prediction of percutaneous penetration. Cardiff: STS, 1995: C68
24. Feldmann RJ, Maibach HI. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54 (5): 399-404
25. Walters KA, Brain KR, Howes D, et al. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food Chem Toxicol 1997; 35 (12): 1219-25
26. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies. VI: preparation of the barrier layer. J Pharm Sci 1986; 75 (5): 487-91
27. Gupta VK, Zatz JL, Rerek M. Percutaneous absorption of sunscreens through micro-yucatan pig skin in vitro. Pharm Res 1999; 16 (10): 1602-7
28. Jiang R, Benson HA, Cross SE, et al. In vitro human epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 from a range of solvents. Pharm Res 1998; 15 (12): 1863-8
29. Benson HAE, Nocente ML, Roberts MS. Penetration of benzophenone-3 through human epidermis from a range of topical formulations. J Pharm Pharmacol 1999; 51 Suppl.: 185
30. Nakai JS, Chu I, Li-Muller A, et al. Effect of environmental conditions on the penetration of benzene through human skin. J Toxicol Environ Health 1997; 51 (5): 447-62
31. Morgan TM, Reed BL, Finnin BC. Enhanced skin permeation of sex hormones with novel topical spray vehicles. J Pharm Sci 1998; 87 (10): 1213-8
32. US National Cancer Institute. Sunscreens. Class study report; Contract No. NO1-CP-71082 (7/89). Rockville MD: Tracor Technological Resources Inc., 1989
33. Knowland J, McKenzie EA, McHugh PJ, et al. Sunlight-induced mutagenicity of a common sunscreen ingredient [see comments]. FEBS Lett 1993; 324 (3): 309-13
34. Nishi J, Ogura R, Sugiyama M, et al. Involvement of active oxygen in lipid peroxide radical reaction of epidermal homogenate following ultraviolet light exposure. J Invest Dermatol 1991; 97 (1): 115-9
35. Norrins NL. Free radical formation in the skin following exposure to ultraviolet light. J Invest Dermatol 1962; 39: 445-8
36. Gasparro FP. The molecular basis of UV-induced mutagenicity of sunscreens. FEBS Lett 1993; 336 (1): 184-5
37. Gasparro FP. UV-induced photoproducts of para-aminobenzoid acid. Photodermatology 1985; 2: 151-7
38. Gasparro FP. PABA: friend or foe [editorial]? Photo Dermatol 1986; 3 (2): 61-3
39. Cosmetic Ingredient Review Panel. Final report on the safety assessment of benzophenones -1, -3, -4, -5, -9, and -11. J Am Coll Toxicol 1983; 2: 35-77
40. Patel NP, Highton A, Moy RL. Properties of topical sunscreen formulations. A review. J Dermatol Surg Oncol 1992; 18 (4): 316-20
41. National Toxicology Program. Draft NTP technical report on the toxicity studies of 2-hydroxy-4-methoxybenzophenone in F344/N rats and B6C3F1 mice (dose fed and dermal studies). NTP Toxicol 1991: 21
42. Xu C, Parsons PG. Cell cycle delay, mitochondrial stress and uptake of hydrophobic cations induced by sunscreens in cultured human cells. Photochem Photobiol 1999; 69 (5): 611-6
43. Chou HJ, Yates RL, et al. Determination of 2-ethylhexyl 4-(N-methyl-N-nitrosamino) benzoate in commercial sunscreens and cosmetic products. J AOAC Int 1995; 78 (6): 1378-83
44. Dunkel VC, San RH, et al. Evaluation of the mutagenicity of an N-nitroso contaminant of the sunscreen Padimate O: N-nitroso-N-methyl-p-aminobenzoic acid, 2-ethylhexyl ester (NPABAO). Environmental and Molecular Mutagenesis 1992; 20 (3): 188-98
45. Loeppky RN, Hastings, et al. Nitrosation of tertiary aromatic amines related to susncreen ingredients. IARC Sci Publ 1991; 105: 244-52
46. Westin JB, Speigelhalder, et al. Assay of suntan lotions for the carcinogenic, nonvolatile N-nitrosamine N-nitrosodiethanolamine. Cancer Lett 1990; 50 (2): 157-60
47. Chu I, Dick D, Bronaugh R, et al. Skin reservoir formation and bioavailability of dermally administered chemicals in hairless guinea pigs. Food Chem Toxicol 1996; 34 (3): 267-76